Dexcom (DXCM) is a global leader in CGM, continuous glucose monitoring, for people with diabetes. As someone in this field I love the future of CGM for diabetes management, no more pricks for blood and more accurate readings without as much of the scary high or low blood sugar readings. There are other CGM companies but DXCM definitely seems far and ahead of the others.
Stock Split announced to begin June 10, 2022 after stockholder approval. Outstanding stocks before May 19, 2022 should be traded on a 4:1 basis.
Leave a Reply